Pediatrix Medical Group, Inc. (NYSE:MD) Stock Now Rated “Hold” by Wall Street Brokerages

Pediatrix Medical Group, Inc. (NYSE:MD) has received a consensus recommendation of “Hold” from the six analysts that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $26.60.

Several equities analysts have commented on the company. Truist Financial raised their price objective on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their target price for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Weiss Ratings raised Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, September 9th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a report on Wednesday, August 5th.

Pediatrix Medical Group Trading Down 0.8%

Shares of MD stock opened at $25.66 on Friday. The firm has a market cap of $2.08 billion, a P/E ratio of 12.28 and a beta of 0.64. The business has a 50-day moving average price of $26.39 and a two-hundred day moving average price of $24.02. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group has a 12-month low of $15.69 and a 12-month high of $27.94.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The company had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. During the same quarter in the previous year, the company posted $0.53 EPS. Pediatrix Medical Group’s revenue for the quarter was up 4.1% on a year-over-year basis. Equities analysts anticipate that Pediatrix Medical Group will post 2.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds have recently made changes to their positions in MD. BlackRock Inc. purchased a new stake in Pediatrix Medical Group during the second quarter worth $347,383,000. Dimensional Fund Advisors LP increased its holdings in Pediatrix Medical Group by 8.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company’s stock worth $82,496,000 after buying an additional 287,696 shares during the period. Wasatch Advisors LP lifted its position in Pediatrix Medical Group by 21.9% during the second quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock valued at $63,297,000 after purchasing an additional 448,360 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Pediatrix Medical Group by 12.9% in the first quarter. Renaissance Technologies LLC now owns 1,532,300 shares of the company’s stock worth $32,776,000 after buying an additional 174,600 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of Pediatrix Medical Group by 52.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 975,133 shares of the company’s stock worth $20,185,000 after purchasing an additional 335,733 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc is a physician-led healthcare services company that provides specialized medical care for women, infants and children. The company partners with hospitals and health systems to deliver care through physician practices, neonatal intensive care units and other hospital-based programs.

Its services include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric hospital medicine and other pediatric subspecialties. Pediatrix physicians care for patients before, during and after childbirth, as well as children requiring specialized or critical care.